Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670316 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 371
- Enrollment target
NCT03670316: Completed Phase 4 study, sponsored by University of Alabama at Birmingham.
NCT03670316 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 371 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03670316, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 371 participants
- Enrollment target
Study Summary
To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.
Primary Outcome
Self-report of cigarette smoking in the last 7 days
Interventions
- DRUG Algorithm Treatment
- OTHER Quitline only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2025-06-30 |
| Phase | Phase 4 |
What the finished NCT03670316 record still lists
NCT03670316 is an interventional study that assigns participants to a tested intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 2 interventions - of which Algorithm Treatment is the first listed.
NCT03670316 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03670316 about?
NCT03670316 is a clinical study titled "Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care". To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.
What is the current status of trial NCT03670316?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 371 participants. The study started on 2020-08-17. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT03670316?
The interventions under investigation include: Algorithm Treatment (DRUG), Quitline only (OTHER).
Who is sponsoring clinical trial NCT03670316?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03670316's enrollment target sits among peer trials
371 223rd of 2000 higher than 1,778 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI